BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

993 related articles for article (PubMed ID: 16078320)

  • 1. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Hanly JG; Fisk JD; McCurdy G; Fougere L; Douglas JA
    J Rheumatol; 2005 Aug; 32(8):1459-6. PubMed ID: 16078320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
    J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
    Mok CC; Lau CS; Wong RW
    J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study.
    Harboe E; Tjensvoll AB; Maroni S; Gøransson LG; Greve OJ; Beyer MK; Herigstad A; Kvaløy JT; Omdal R
    Ann Rheum Dis; 2009 Oct; 68(10):1541-6. PubMed ID: 18930990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
    Mikdashi J; Handwerger B
    Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
    Sanna G; Bertolaccini ML; Cuadrado MJ; Laing H; Khamashta MA; Mathieu A; Hughes GR
    J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.
    Hanly JG; Robichaud J; Fisk JD
    J Rheumatol; 2006 Aug; 33(8):1553-8. PubMed ID: 16881112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus.
    Mikdashi J; Krumholz A; Handwerger B
    Neurology; 2005 Jun; 64(12):2102-7. PubMed ID: 15985581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of lifetime mood and panic-agoraphobic spectrum symptoms on quality of life of patients with rheumatoid arthritis.
    Piccinni A; Maser JD; Bazzichi L; Rucci P; Vivarelli L; Del Debbio A; Catena M; Bombardieri S; Dell'Osso L
    Compr Psychiatry; 2006; 47(3):201-8. PubMed ID: 16635649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery.
    Kozora E; Ellison MC; West S
    Arthritis Rheum; 2006 Aug; 55(4):628-35. PubMed ID: 16874786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.
    Ainiala H; Dastidar P; Loukkola J; Lehtimäki T; Korpela M; Peltola J; Hietaharju A
    Scand J Rheumatol; 2005; 34(5):376-82. PubMed ID: 16234185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
    Wang M; Gladman DD; Ibañez D; Urowitz MB
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How "soft" are soft neurological signs? The relationship of subjective neuropsychiatric complaints to cognitive function in systemic lupus erythematosus.
    Denburg SD; Stewart KE; Hart LE; Denburg JA
    J Rheumatol; 2003 May; 30(5):1006-10. PubMed ID: 12734896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.
    Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E
    Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in patients with systemic lupus erythematosus.
    Hanly JG; Fisk JD; Sherwood G; Jones E; Jones JV; Eastwood B
    J Rheumatol; 1992 Apr; 19(4):562-7. PubMed ID: 1593578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.
    Sibbitt WL; Brandt JR; Johnson CR; Maldonado ME; Patel SR; Ford CC; Bankhurst AD; Brooks WM
    J Rheumatol; 2002 Jul; 29(7):1536-42. PubMed ID: 12136916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive dysfunction in patients with systemic lupus erythematosus: a controlled study.
    Antonchak MA; Saoudian M; Khan AR; Brunner HI; Luggen ME
    J Rheumatol; 2011 Jun; 38(6):1020-5. PubMed ID: 21459946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.
    Harrison MJ; Ravdin LD; Lockshin MD
    Arthritis Rheum; 2006 Aug; 54(8):2515-22. PubMed ID: 16868972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.
    Ikenouchi-Sugita A; Yoshimura R; Okamoto T; Umene-Nakano W; Ueda N; Hori H; Katsuki A; Saito K; Tanaka Y; Nakamura J
    World J Biol Psychiatry; 2010 Mar; 11(2):121-8. PubMed ID: 20109107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.